Cathepsin K

Feb 13, 2020

Medivir AB: Year End Report January-December 2019

Jan 20, 2020

Medivir's Phase II Study of MIV-711 in Patients With Osteoarthritis Published in Annals of Internal Medicine

Nov 27, 2019

Medivir AB - Interim Report January - September 2019

Aug 28, 2019

Medivir AB - Interim Report January - June 2019

May 06, 2019

Safety and Efficacy Data From the MIV-711 Phase II Open Label Extension Study Presented at the OARSI World Congress

Oct 19, 2018

New Data From the MIV-711 Phase II Program Will be Presented at the ACR Annual Meeting on October 21

Jul 27, 2018

MIV-711 Osteoarthritis Phase IIa Extension Study Outcomes Show Continuing Positive Effect on Joint Structure

Jun 28, 2018

Medivir Announces Positive Top-line Results From the MIV-711 Osteoarthritis Phase IIa Extension Study

Apr 26, 2018

Medivir AB: Data From the MIV-711 Initial Phase IIa Study Will be Presented at the OARSI World Congress on April 27

Nov 09, 2017

Medivir: MIV-711 Phase IIa Osteoarthritis Study Data Presented as a Late Breaking Poster at the Annual Meeting of the American College for Rheumatology

Oct 24, 2017

Medivir Receives FDA Fast Track Designation for MIV-711 for the Treatment of OA